Literature DB >> 21969269

From victim to survivor to thriver: helping women with primary ovarian insufficiency integrate recovery, self-management, and wellness.

Evelina Weidman Sterling1, Lawrence M Nelson.   

Abstract

Most women discover that they are infertile in a gradual manner after many failed attempts at conception. By contrast, most women with primary ovarian insufficiency (POI) uncover their infertility as part of an evaluation of other presenting complaints, frequently before attempts at conception have even been contemplated. The most common words women use to describe how they feel in the hours after getting the diagnosis of POI are "devastated," "shocked," and "confused." Clearly, the news propels some patients onto a difficult journey. POI is a serious and incurable chronic disease. The diagnosis is more than infertility and affects a woman's physical and emotional well-being. Management of the condition must address both. Patients face the acute shock of the diagnosis, associated stigma of infertility, grief from the death of dreams, anxiety from the disruption of life plans, confusion around the cause, symptoms of estrogen deficiency, worry over the associated potential medical sequelae such as reduced bone density and cardiovascular risk, and the uncertain future that all of these factors create. There is a need for an evidenced-based integrated program to assist women with POI in navigating the transition to acceptance of the diagnosis, ongoing management of the condition, and ongoing maintenance of wellness in the presence of the disorder. A health-centered approach can gradually replace the disease-centered approach and put patients in partnerships with professional health-care providers. Ideally, the journey transitions each patient from seeing herself as a victim, to a survivor, to a woman who is thriving. © Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2011        PMID: 21969269      PMCID: PMC4350677          DOI: 10.1055/s-0031-1280920

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  84 in total

Review 1.  Towards a definition of wellness.

Authors:  S Mackey
Journal:  Aust J Holist Nurs       Date:  2000-10

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 3.  A model of mourning: change in schemas of self and other.

Authors:  M J Horowitz
Journal:  J Am Psychoanal Assoc       Date:  1990

4.  The lived experience of premature ovarian failure.

Authors:  S A Orshan; K K Furniss; C Forst; N Santoro
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2001 Mar-Apr

5.  Assessing the emotional needs of women with spontaneous premature ovarian failure.

Authors:  Allison A Groff; Sharon N Covington; Lynn R Halverson; O Ray Fitzgerald; Vien Vanderhoof; Karim Calis; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2005-06       Impact factor: 7.329

6.  Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.

Authors:  Marianne Canonico; Emmanuel Oger; Geneviève Plu-Bureau; Jacqueline Conard; Guy Meyer; Hervé Lévesque; Nathalie Trillot; Marie-Thérèse Barrellier; Denis Wahl; Joseph Emmerich; Pierre-Yves Scarabin
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

7.  Women with spontaneous 46,XX primary ovarian insufficiency (hypergonadotropic hypogonadism) have lower perceived social support than control women.

Authors:  Susan A Orshan; June L Ventura; Sharon N Covington; Vien H Vanderhoof; James F Troendle; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2008-10-01       Impact factor: 7.329

8.  Resilient individuals use positive emotions to bounce back from negative emotional experiences.

Authors:  Michele M Tugade; Barbara L Fredrickson
Journal:  J Pers Soc Psychol       Date:  2004-02

9.  Obstetric outcomes in donor oocyte pregnancies compared with advanced maternal age in in vitro fertilization pregnancies.

Authors:  Sacha A Krieg; Melinda B Henne; Lynn M Westphal
Journal:  Fertil Steril       Date:  2007-08-29       Impact factor: 7.329

10.  Fragile X syndrome: diagnostic and carrier testing.

Authors:  Stephanie Sherman; Beth A Pletcher; Deborah A Driscoll
Journal:  Genet Med       Date:  2005-10       Impact factor: 8.822

View more
  3 in total

1.  mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy.

Authors:  Kara N Goldman; Devon Chenette; Rezina Arju; Francesca E Duncan; David L Keefe; Jamie A Grifo; Robert J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-07       Impact factor: 11.205

Review 2.  A new approach to primary ovarian insufficiency.

Authors:  Saima Rafique; Evelina W Sterling; Lawrence M Nelson
Journal:  Obstet Gynecol Clin North Am       Date:  2012-12       Impact factor: 2.844

Review 3.  Pathophysiology and management of classic galactosemic primary ovarian insufficiency.

Authors:  Synneva Hagen-Lillevik; John S Rushing; Leslie Appiah; Nicola Longo; Ashley Andrews; Kent Lai; Joshua Johnson
Journal:  Reprod Fertil       Date:  2021-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.